CSI Market
Sign In | Register

Pear Therapeutics Inc (PEAR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PEAR Annual Cash Flow →
The data below summarizes Pear Therapeutics Inc's cash flow activity from Dec 31 2021 to Dec 31 2022, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
12 Months 		(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Operating Activities
Income-75.49
Depreciation & amortization3.35
Amortization of Other Assets1.07
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-45.34
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation13.53
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Interest Earned On Marketable Securities Held In Trust Account-
Gain Loss On Issuance Of Convertible Preferred Stock-
Operating Lease Right Of Use Asset Amortization Expense1.29
Gain Loss On Convertible Preferred Stock-
Change In Fair Value Adjustment Of Warrants-6.12
Embedded Derivative Gain Loss On Embedded Derivative Net-0.68
Impairment Of Intangible Assets Excluding Goodwill0.06
Increase Decrease In Contract With Customer Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-5.15
Increase (Decrease) in Accounts Payable0.00
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-1.84
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.93
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.73
Discontinued operations0.00
Net Cash flow from Operating Activities-113.90
Investing Activities
Capital Expenditures-3.47
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities60.05
Payments to Acquire Available-for-sale Securities, Debt-66.04
Real Estate Investments0.00
Payments For Milestone Payment-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-9.46
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.16
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Reverse Recapitalization Transaction-
Payment Of Deferred Offering Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.16
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-117.37
Total Cash Flow-121.20
4 historic quarters locked

Sign in to unlock the full Pear Therapeutics Inc cash flow history.

Sign In Create Free Account

About Pear Therapeutics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001835567-23-000018

Figures are derived from filed reports and may be restated. Historical data is subject to revision.